{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"The study was terminated early having met the pre-specified stopping rule which required 3 or more cohorts with at least 10 patients each or 2 cohorts with at least 15 patients each in the first 50 patients with informative biopsies."},"pointOfContact":{"email":"KarenD_Wright@dfci.harvard.edu","organization":"Dana-Farber Cancer Institute","phone":"617.632.6740","title":"Karen Wright"}}